Oct 3, 2014
1
1
The world's first induced pluripotent stem cell (iPSC) trial launched in September. A woman blinded by "wet" age-related macular degeneration received retinal pigment epithelial cells (RPEs) that were made thusly: her skin cells were reprogrammed into pluripotent cells. The pluripotent cells were differentiated, using growth factors, into RPEs. A sheet of these RPEs were transplanted into one of her retinas. The trial was launched under the auspices of Riken, a prestigious Japan insitute. Nobel Prize winning iPSC creator Shinya Yamanaka has overseen the planning.

http://www.dddmag.com/articles/2014/10/japan-starts-world-first-stem-cell-trial-plans-more
 
  • Like
Reactions: Dave89

MstaKing10

10+ Year Member
Aug 17, 2009
572
130
Status
Attending Physician
How are these stem cells delivered?
The ACT trial has shown some interesting results. Safety is the primary concern. Not sure I would qualify this as the first stem cell trial, that's a bit misleading as the ACT trial pre-dates this although they used embryonic stem cells. I think a stem cell trial here in the states will be approved soon.